Eplerenone Patent Expiration
Eplerenone is Used for treating hypertension, heart failure, and conditions related to hyperaldosteronism, often in combination with an ACE inhibitor. It was first introduced by Upjohn Us 2 Llc
Eplerenone Patents
Given below is the list of patents protecting Eplerenone, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Inspra |
US6863902 (Pediatric) | Immediate release eplerenone compositions |
Oct 10, 2020
(Expired) | Upjohn |
| Inspra |
US6410054 (Pediatric) | Immediate release eplerenone compositions |
Jun 08, 2020
(Expired) | Upjohn |
| Inspra |
US6495165 (Pediatric) | Eplerenone compositions having improved bioavailability |
Jun 08, 2020
(Expired) | Upjohn |
| Inspra |
US6534093 (Pediatric) | Immediate release eplerenone compositions |
Jun 08, 2020
(Expired) | Upjohn |
| Inspra |
US6558707 (Pediatric) | Immediate release eplerenone compositions |
Jun 08, 2020
(Expired) | Upjohn |
| Inspra |
US7157101 (Pediatric) | Micronized eplerenone compositions |
Jun 08, 2020
(Expired) | Upjohn |
| Inspra |
US6410524 (Pediatric) | Combination therapy of angiotensin converting enzyme inhibitor and aldosterone antagonist for reducing morbidity and mortality from cardiovascular disease |
May 05, 2020
(Expired) | Upjohn |
| Inspra |
US6747020 (Pediatric) | Methods of treating heart failure and hypertension using combinations of eplerenone and an angiotensin converting enzyme inhibitor |
May 05, 2020
(Expired) | Upjohn |
| Inspra | US6863902 | Immediate release eplerenone compositions |
Apr 10, 2020
(Expired) | Upjohn |
| Inspra | US6410054 | Immediate release eplerenone compositions |
Dec 08, 2019
(Expired) | Upjohn |
| Inspra | US6495165 | Eplerenone compositions having improved bioavailability |
Dec 08, 2019
(Expired) | Upjohn |
| Inspra | US6534093 | Immediate release eplerenone compositions |
Dec 08, 2019
(Expired) | Upjohn |
| Inspra | US6558707 | Immediate release eplerenone compositions |
Dec 08, 2019
(Expired) | Upjohn |
| Inspra | US7157101 | Micronized eplerenone compositions |
Dec 08, 2019
(Expired) | Upjohn |
| Inspra | US6410524 | Combination therapy of angiotensin converting enzyme inhibitor and aldosterone antagonist for reducing morbidity and mortality from cardiovascular disease |
Nov 05, 2019
(Expired) | Upjohn |
| Inspra | US6747020 | Methods of treating heart failure and hypertension using combinations of eplerenone and an angiotensin converting enzyme inhibitor |
Nov 05, 2019
(Expired) | Upjohn |
Eplerenone's Family Patents
